Caricord
Caricord (Lifebank by Celularity) is a direct-to-consumer cord blood and placental tissue banking service that preserves newborn stem cells using patented processing methods, serving expectant families through subscription-based long-term storage.
- Company typePrivate
- Founded2013
- HeadquartersIrvine, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Caricord does
Caricord, operating under the brand "Lifebank By Celularity," is a privately held cord blood and placental tissue banking service headquartered in Cedar Knolls, New Jersey, with an additional office in Florham Park, New Jersey. The company preserves hematopoietic stem cells (HSCs) extracted from umbilical cord blood — FDA-approved for treatment of 80+ diseases — and mesenchymal stem cells (MSCs) extracted from placental tissue, which have applications in regenerative medicine including skeletal tissue repair. Processing and storage operate through a strategic affiliation with Celularity, a biotechnology company focused on placental-derived stem cell therapies that provides the underlying scientific and technical infrastructure.
Lifebank serves expectant parents and families through a direct-to-consumer model. Customers enroll online, schedule planning sessions, and have stem cell collections picked up by medical couriers immediately after birth. The product portfolio includes cord blood banking, placental banking, a combined Cord + Placental Tissue package, a Sibling Program offering discounted services for families with an existing child who may benefit from a stored match, and a public Donation Program for altruistic contribution to other patients. The company markets through its website, educational content, scheduled planning sessions, and earned media coverage in outlets including Fox Business, NBC, CBS, Wall Street Journal, Science AAAS, New York Times, and Life Science Leader.
The revenue model is subscription-based with annual recurring billing for long-term cryogenic storage of stem cell collections. Pricing tiers are available on the company's website but are not detailed in the source material. As a subsidiary of Celularity, Lifebank's strategic positioning is closely tied to its parent's broader cell therapy platform, which provides both scientific credibility and operational infrastructure.
Caricord firmographics
Firmographics- Name
- Caricord
- Legal name
- Lifebank
- Website
- https://caricord.com
- Company type
- Private
- Founded year
- 2013
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Caricord (Lifebank by Celularity) is a direct-to-consumer cord blood and placental tissue banking service that preserves newborn stem cells using patented processing methods, serving expectant families through subscription-based long-term storage.
- Ownership category
- akta.pro rank
Caricord industry classification
Industry- Product category
- Stem Cell Banking Services
- NAICS
- Blood and Organ Banks (621991)
- SIC
- Biological Products, (No Disgnostic Substances) (2836)
- akta.pro primary industry
- Cell & Tissue Banking (biobanking, cord blood/tissue) (HLAAAGAE)
Keywords
Where Caricord is headquartered
LocationHeadquarters
- HQ city
- Irvine
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Caricord business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Personnel, Marketing or Sales, Technology or R&D, Infrastructure, Supply Chain
Revenue model
- Cord Blood Banking: Storage of umbilical cord blood containing hematopoietic stem cells (HSCs) for future medical treatments. FDA-approved to treat more than 80 diseases.
- Placental Banking: Storage of placental tissue containing mesenchymal stem cells (MSCs) with potential applications in regenerative medicine for skeletal tissue repair.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | Pricing & Packages available on website |
Go-to-market motion1 record
Distribution channels1 record
Marketing channels4 records
Caricord product offering
Product offeringCore offering
Caricord markets family stem cell banking services that preserve umbilical cord blood and placental tissue after birth, using patented processing methods through the Lifebank By Celularity™ brand. Core offerings include cord blood banking (HSCs for cellular therapies, FDA-approved for 80+ diseases), placental banking (MSCs for regenerative medicine), combined cord and placental packages, a sibling discount program, and a public donation program. Customers enroll online, schedule planning sessions, and rely on a medical courier to collect the sample at birth.
Product overview
Lifebank By Celularity™ (Caricord) operates as a unified cord blood and placental banking platform offering stem cell preservation services. The core product portfolio centers on cord blood banking (preserving hematopoietic stem cells for cellular therapies) and placental banking (preserving mesenchymal stem cells for regenerative medicine). Additional offerings include combined cord and placental tissue packages, a sibling discount program, and a public donation program. The company utilizes proprietary patented processing methods and is operated by Celularity.
Differentiator
Problem solved
Functional benefit
Products and services
- Cord Blood Banking Umbilical cord blood banking service that preserves hematopoietic stem cells (HSCs) for cellular therapies; marketed to expectant parents. Cord blood stem cells are FDA-approved to treat more than 80 diseases.
- Placental Banking Preservation service for placental tissue and placental blood containing mesenchymal stem cells (MSCs) and hematopoietic stem cells, with potential applications in regenerative medicine including bone, cartilage, and fat tissue repair; marketed to expectant parents.
- Cord + Placental Tissue Package Combined banking package that preserves both umbilical cord blood (HSCs) and placental tissue (MSCs) for families seeking comprehensive stem cell preservation; sold as a single offering.
- Sibling Program Discounted cord blood banking program for families with an existing child who may benefit from stored stem cells, enabling biological-sibling stem cell compatibility use cases.
- Donation Program Public donation program allowing families to donate cord blood and placental stem cells for use by unrelated patients in need, supporting the broader public stem cell supply.
Companies that use Caricord
Customer profileSegments1 record
Ideal customer profiles1 record
Caricord technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Caricord partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- CelularitycoreLifebank operates as 'Lifebank By Celularity' using Celularity's processing and storage facilities. The partnership leverages Celularity's cell therapy platform and proprietary processing methods for stem cell banking services. Video content references 'Lifebank's patented processing methods' and 'Celularity Virtual Tour' showing inside look at processing and storage operations.
Recent moves5 records
Expansion highlights4 records
Caricord competitors and assessment
Company assessmentDirect peers
- Cord Blood Registry (CBR): Largest U.S. private cord blood bank offering cord blood and cord tissue storage with a direct-to-consumer model targeting expectant parents — directly comparable to Lifebank's core banking proposition.
- ViaCord: Private family cord blood and cord tissue bank (owned by Sema4 / formerly PerkinElmer) offering subscription storage with direct-to-consumer acquisition — overlapping product set and customer base with Lifebank.
- AlphaCord: U.S. private cord blood and tissue bank with direct-to-consumer enrollment and annual storage fees — same niche consumer-services revenue model.
- Americord Registry: Private cord blood, cord tissue, and placenta blood bank selling directly to expectant parents with annual storage plans — same category, same buyer, similar premium positioning.
- StemCyte: Hybrid public/private cord blood bank offering family banking alongside public donation programs — comparable product mix including donation SKUs similar to Lifebank's donation module.
- Maze Cord Blood Bank: Cord blood banking service operated by Maze Laboratories, targeting expectant parents with subscription storage — direct overlap in product, customer segment, and go-to-market motion.
- Cryo-Cell International: Publicly traded cord blood bank offering private cord blood and menstrual stem cell banking with annual storage fees — comparable business model, recurring revenue structure, and DTC funnel.
Broad incumbents
- Celularity: Lifesbank's parent company and broader placental-derived cell therapy and biologics platform — comparable in tissue/cell processing technology but operating at the biotech platform level rather than consumer banking.
Others
- BioLife Solutions: Supplier of cryopreservation media and cold-chain tools used by cell and tissue banks including cord blood banks — ecosystem participant rather than competitor, but operationally linked to Lifebank's storage process.
- Cryoport Systems: Provider of temperature-controlled logistics for life sciences, including stem cell and reproductive medicine shipments — analogous 'last-mile cold chain' role to Lifebank's medical courier pickup model.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights6 records
Customer concentration
Caricord social profiles
Digital presenceCaricord financial estimates
Financial estimateRevenue estimate
Valuation estimate
Caricord leadership team
Management profileNumber of profiles
Caricord funding detail
Funding detailFunding overview
Funding rounds2 records
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Caricord M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Caricord
What does Caricord do?
Caricord markets family stem cell banking services that preserve umbilical cord blood and placental tissue after birth, using patented processing methods through the Lifebank By Celularity™ brand. Core offerings include cord blood banking (HSCs for cellular therapies, FDA-approved for 80+ diseases), placental banking (MSCs for regenerative medicine), combined cord and placental packages, a sibling discount program, and a public donation program. Customers enroll online, schedule planning sessions, and rely on a medical courier to collect the sample at birth.
Is Caricord a public or private company?
Caricord is a private company. It is classified as corporate owned and is currently operating.
When was Caricord founded?
Caricord was founded in 2013. It employs 1 to 10 people.
Where is Caricord based?
Caricord is headquartered in Irvine, United States, in the North America region.
How does Caricord make money?
Two revenue lines are on record. Cord Blood Banking is the primary driver. The others are placental Banking.
Who are Caricord's main competitors?
Direct peers on record are Cord Blood Registry (CBR), ViaCord, AlphaCord, Americord Registry, StemCyte, Maze Cord Blood Bank and Cryo-Cell International. Celularity is listed as a broad incumbent. Others are BioLife Solutions and Cryoport Systems.
Does Caricord have an API?
No public API is recorded for Caricord.
What industry is Caricord in?
Caricord's product category is Stem Cell Banking Services. Its primary akta.pro industry code is HLAAAGAE, Cell & Tissue Banking (biobanking, cord blood/tissue). Its NAICS code is 621991 and its SIC code is 2836.